|
|
News for Healthier Living
Novel Drug Candidate Based on HSS Research Secures $70M Series A Financing and Will Begin Its First Clinical Trial in Europe
SciRhom GmbH, a biotech startup co-founded by Hospital for Special Surgery (HSS), recently secured a 63 million euro (US$70 million) Series A financing round to support the clinical development of its novel drug candidate, SR-878. The round was co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, with participation from new investor Bayern Kapital and existing investors. This news follows the company's recently received approval from Austrian regulatory authorities (BASG/AGES) required to commence its first-in-human Phase I clinical trial in Europe this fall.
October 15, 2024
October 19 2024October 18 2024 - Study Finds Opt-Out Treatment Helps Smokers Quit, Even Those with Low Motivation
- A Cancer Diagnosis Takes Devastating Toll on Family Finances
- Music Might Speed Your Recovery From Surgery
- Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains Low
- Texas AG Sues Dallas Doctor Over Transgender Care for Minors
- ACI Report Offers "State of the Science" on In Vitro Methods for Cleaning Product Safety Assessment
- Love Bread & Pasta? Humans' Hunger for Carbs Has Ancient Roots
- Real-World Study Confirms RSV Vaccine's Protective Power for Seniors
- AI-powered Home Monitoring Device May Improve AMD Care, Save Money
- Family, Friends Crucial to Whether You Get Screened for Cancer
- Fitness, Activity Boosts Kids' Mental Health, Too
- Global Study Finds PFAS 'Forever Chemicals' Common in Tap, Bottled Water
- Sports Concussion Outcomes Can Be Made Worse By Depression
- Could Light Therapy Treat Dry AMD?
- American Academy of Ophthalmology Launches VR Education Program in Collaboration with FundamentalVR to Improve Ophthalmic Care Around the World
- An Ill Kitten in Nebraska Sparked Efforts to Stamp Out Rabies' Spread
- Listening to Music May Speed Up Recovery from Surgery
- Emotional and Financial Concerns of Breast Cancer Patients Are Often Unmet
- ACS Program Cuts Surgical Deaths and Improves Care for Older Adults, Studies Show
- Cancer Diagnoses Linked to Lasting Financial Challenges, Studies Find
- Bariatric Surgery Is More Cost Effective Than Newer Weight Loss Drugs Alone
- How Liver Tissue from the International Space Station may Transform Tissue Engineering
- Groundbreaking Surgical Technique Makes Combined Face and Whole-Eye Transplantation a Reality
- Preoperative Nutrition Program Cuts Surgery Costs and Complications
- For Younger Adults, a Colorectal Cancer Diagnosis Impacts Their Lives Much Differently Than Older Adults
- Evergreen Theragnostics Opens CCK2-VIEW, a Phase II Small Cell Lung Cancer Clinical Trial, in the European Union
October 17 2024October 16 2024 - Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin Lymphoma
- New Combo Drug Therapy Halves Death Risk From Advanced Hodgkin Lymphoma
- Kidney Transplants Safe When Donor, Recipient Both HIV-Positive
- For Multiple Sclerosis, Medication and Cognitive Behavioral Therapy Can Reduce Fatigue
- Study Finds HIV-To-HIV Kidney Transplants Are as Safe and Effective as Those Using Organs From Donors Without HIV
- All Too Human: Racial Disparities in Pain Assessment Expose AI's Flawed Beliefs About Race
- Video and Transcript Available: Virtual Press Briefing on Embargoed Hodgkin Lymphoma Clinical Trial
- In Landmark Study, Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma
- Study: Breast Cancer Drug Shows Potential for Rare Appendix Cancer
- Are Health Care Disparities Tied to Stroke Treatments?
- Which Clot-Busting Drug Is Tied to Better Recovery After Stroke?
- COVID-19 Study Reveals Virus-Induced Inflammation During Pregnancy, Redefines Vertical Transmission
- High Flux Isotope Reactor a Fit for Nobel Laureate's Designer Proteins
- Serena Williams Has Large Benign Cyst Removed From Neck
- Mayo Clinic Platform_Accelerate and JETRO Japan join forces with U.S. Healthcare Immersion Program
- Study Finds Widespread Exposure to Hormone-Disrupting Chemical During Pregnancy
- When Complications Strike After Heart Surgery, Women More Likely to Die Than Men
- Marc-Andre Legault: Optimizing Drug Therapy with Bioinformatics
- Most Older Americans Don't Trust AI-Generated Health Info, Survey Finds
- Women More Likely Than Men to Die After Heart Surgery Complications
- Challenging Current Understanding, Study Reveals Rapid Release of Dopamine Not Needed for Initiating Movement
- Biden Administration Uses Wartime Powers to Help Restart IV Fluid Plant in North Carolina
- Bowel Prep Quality, Insurance Barriers to Care Included in the October Issue of AJG
- Ozarks Healthcare Partners with Avo to Integrate AI-Powered Decision Support in the EHR
- Researchers Identify New Protein Pathway, Biological Function Important for Cell Migration, Cancer Metastasis
- Running Hot, Flying Light
- More Kids Having Seizures After Swallowing Rx Painkillers, Synthetic Pot
- Poll Finds Public Fears Over RSV Have Eased, Although It Remains a Threat
- Obesity Could Cause 40% of Hormone-Positive Breast Cancers in Older Women
- Planes' Air Ventilation Can't Spread Nut Allergens to Passengers: Study
- Men and Women Use Different Biological Systems to Reduce Pain
- ERs See More Trauma Patients on Smog-Filled Days
- Most Older Adults Don't Trust AI-Generated Health Information -- but Many Aren't Sure What to Trust
- Feeling Sleepy and Worried About Your Mental Alertness?
October 15 2024October 14 2024October 13 2024October 12 2024October 11 2024October 10 2024October 9 2024October 8 2024October 7 2024October 6 2024October 5 2024
|
|
|
|
|